GFACX
Price
$73.04
Change
+$0.40 (+0.55%)
Updated
Sep 11 closing price
Net Assets
353.07B
WPASX
Price
$47.57
Change
+$0.76 (+1.62%)
Updated
Sep 11 closing price
Net Assets
421.64M
Interact to see
Advertisement

GFACX vs WPASX

GFACX vs WPASX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. WPASX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and WPASX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 353B vs. WPASX (422M). GFACX (0.00) and WPASX (0.00) have matching dividends . GFACX was incepted earlier than WPASX: GFACX (26 years) vs WPASX (13 years). GFACX (1.35) is less costly to investors than WPASX (1.00). GFACX is a more actively managed with annual turnover of: 32.00 vs. WPASX (18.00). GFACX has a lower initial minimum investment than WPASX: GFACX (250) vs WPASX (2500). GFACX annual gain was more profitable for investors over the last year : -2.39 vs. WPASX (-15.44). GFACX return over 5 years is better than : 3.85 vs. WPASX (-23.32).
GFACXWPASXGFACX / WPASX
Total Expense Ratio1.351.00135%
Annual Report Gross Expense Ratio1.351.00135%
Fund Existence26 years13 years-
Gain YTD8.529-6.268-136%
Front LoadN/A4%-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets353B422M83,649%
Annual Yield % from dividends0.000.00-
Returns for 1 year-2.39-15.4415%
Returns for 3 years34.46-3.84-897%
Returns for 5 years3.85-23.32-17%
Returns for 10 years82.3370.15117%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NAMS22.800.94
+4.30%
NewAmsterdam Pharma Company NV
BYRN3.620.09
+2.55%
Byrna Technologies
CX10.690.03
+0.28%
Cemex SAB de CV
RGNX8.53-0.03
-0.35%
REGENXBIO
CRIS1.13-0.03
-2.59%
Curis Inc.